COVID-19 vaccine developer Moderna (Nasdaq:MRNA) has named Arpa Garay as its chief commercial officer starting May 31, 2022. Garay spent more than 15 years at Merck & Co. (NYSE:MRK). In February, she was promoted to the post of chief marketing officer for Merck’s human health division. Garay also was a member of the company’s executive…

President Biden said in his State of the Union address that the U.S. aims to ramp up the use of Pfizer‘s (NYSE:PFE) Plaxovid. The treatment has been in short supply since it won emergency use authorization late last year. Last year, when Merck & Co. (NYSE: MRK) and Pfizer were close to winning regulatory authorization for…